| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in the treatment of human epidermal growth factor receptor 2-positive gastric cancer
|
Kudo, Toshihiro
|
|
|
29 |
9 |
p. 1220-1227
|
artikel
|
| 2 |
AMIGO2 is involved in the spread of peritoneal metastasis in serous ovarian cancer via promoting adhesion to the peritoneal mesothelial cells
|
Iida, Yuki
|
|
|
29 |
9 |
p. 1354-1363
|
artikel
|
| 3 |
An evaluation model of hepatic steatosis based on CT value and serum uric acid/HDL cholesterol ratio can predict intrahepatic recurrence of colorectal cancer liver metastasis
|
Li, Yuan
|
|
|
29 |
9 |
p. 1263-1273
|
artikel
|
| 4 |
Clinical factors predicting the outcome of salvage radiotherapy for patients with biochemical recurrence after radical prostatectomy
|
Fujimoto, Takeru
|
|
|
29 |
9 |
p. 1326-1333
|
artikel
|
| 5 |
Comorbid thrombosis as an adverse prognostic factor in patients with ovarian clear cell carcinoma regardless of staging
|
Yamaguchi, Kohei
|
|
|
29 |
9 |
p. 1347-1353
|
artikel
|
| 6 |
CT-derived skeletal muscle change before immunotherapy predicts survival of advanced gastric cancer: associations with inflammatory markers and liver lipid metabolism
|
Hayano, Koichi
|
|
|
29 |
9 |
p. 1255-1262
|
artikel
|
| 7 |
Difference of oncological efficacy between two immune checkpoint inhibitors following first-line platinum-based chemotherapy in patients with unresectable, metastatic, advanced urothelial carcinoma: a multicenter real-world Japanese cohort
|
Miyake, Makito
|
|
|
29 |
9 |
p. 1311-1325
|
artikel
|
| 8 |
Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201)
|
Ogata, Yutaka
|
|
|
29 |
9 |
p. 1284-1292
|
artikel
|
| 9 |
Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study
|
Tanabe, Kenji
|
|
|
29 |
9 |
p. 1302-1310
|
artikel
|
| 10 |
Marital status after colorectal surgery in familial adenomatous polyposis: a nationwide multicenter study in Japan
|
Fujiyoshi, Kenji
|
|
|
29 |
9 |
p. 1274-1283
|
artikel
|
| 11 |
New therapeutic target molecules for gastric and gastroesophageal junction cancer
|
Kawakami, Hisato
|
|
|
29 |
9 |
p. 1228-1236
|
artikel
|
| 12 |
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs: approval selpercatinib for solid tumor with RET fusion, gumarontinib for non-small cell lung cancer with MET gene exon 14 skipping mutation, momelotinib for myelofibrosis, bexarotene for adult T-cell leukemia/lymphoma, valemetostat for peripheral T-cell lymphoma, and pirtobrutinib for mantle cell lymphoma in Japan
|
Matsumura, Noriomi
|
|
|
29 |
9 |
p. 1207-1208
|
artikel
|
| 13 |
Prediction of response to promising first-line chemotherapy in ovarian cancer patients with residual peritoneal tumors: practical biomarkers and robust multiplex models
|
Kawabata-Iwakawa, Reika
|
|
|
29 |
9 |
p. 1334-1346
|
artikel
|
| 14 |
Prognostic significance of adjuvant chemotherapy in stage I–II endometrial carcinoma patients who underwent lymphadenectomy
|
Suzuki, Jiro
|
|
|
29 |
9 |
p. 1380-1390
|
artikel
|
| 15 |
Risk factors affecting delay of initiating adjuvant chemotherapy for stage III colorectal cancer
|
Maeda, Shingo
|
|
|
29 |
9 |
p. 1293-1301
|
artikel
|
| 16 |
Statistics of bone sarcoma in Japan: report from the population-based cancer registry in Japan
|
Ogura, Koichi
|
|
|
29 |
9 |
p. 1209-1219
|
artikel
|
| 17 |
The diagnostic and prognostic value of tartrate-resistant acid phosphatase isoform 5b for giant cell tumor of bone
|
Toda, Yu
|
|
|
29 |
9 |
p. 1391-1397
|
artikel
|
| 18 |
The miR-199a-5p/HIF1α dual-regulatory axis participates in hypoxia-induced aggressive phenotypes of oral squamous cell carcinoma (OSCC) cells
|
Chen, Xing
|
|
|
29 |
9 |
p. 1244-1254
|
artikel
|
| 19 |
Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer
|
Kochi, Yuki
|
|
|
29 |
9 |
p. 1364-1379
|
artikel
|
| 20 |
Treatment strategy for HER2-negative advanced gastric cancer: salvage-line strategy for advanced gastric cancer
|
Nishida, Naohiro
|
|
|
29 |
9 |
p. 1237-1243
|
artikel
|
Tijdschrift beschrijving